{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:42:54Z","timestamp":1792176174378,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clineuro.2022.107355","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T20:06:21Z","timestamp":1656360381000},"page":"107355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Calcitonin gene-related peptide and neurologic injury: An emerging target for headache management"],"prefix":"10.1016","volume":"220","author":[{"given":"Yusuf","family":"Mehkri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chadwin","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lucke-Wold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Busl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2022.107355_bib1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3389\/fphys.2018.01249","article-title":"The role of calcitonin gene related peptide (CGRP) in neurogenic vasodilation and its cardioprotective effects","volume":"9","author":"Kee","year":"2018","journal-title":"Front Physiol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","article-title":"Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat","volume":"25","author":"Mulderry","year":"1988","journal-title":"Neuroscience"},{"issue":"6237","key":"10.1016\/j.clineuro.2022.107355_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/341076a0","article-title":"Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor","volume":"341","author":"Emeson","year":"1989","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib4","first-page":"1","article-title":"The importance of upper respiratory tract infections in determining chronic pulmonary diseases","volume":"34","author":"Hociot\u0103","year":"1989","journal-title":"Rev. Chir. Oncol. Radio. O R. L Oftalmol. Stomatol Otorinolaringol."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107355_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","article-title":"The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine","volume":"158","author":"Iyengar","year":"2017","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107355_bib6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.brainresrev.2004.09.007","article-title":"Neurobiology in primary headaches","volume":"48","author":"Edvinsson","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107355_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1152\/physrev.00043.2006","article-title":"Physiology and pathophysiology of purinergic neurotransmission","volume":"87","author":"Burnstock","year":"2007","journal-title":"Physiol. Rev."},{"issue":"3\u20134","key":"10.1016\/j.clineuro.2022.107355_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1113\/jphysiol.1901.sp000831","article-title":"On the origin from the spinal cord of the vaso-dilator fibres of the hind-limb, and on the nature of these fibres","volume":"26","author":"Bayliss","year":"1901","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(86)90071-6","article-title":"Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects","volume":"15","author":"Uddman","year":"1986","journal-title":"Regul. Pept."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s10194-018-0848-0","article-title":"The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system","volume":"19","author":"Messlinger","year":"2018","journal-title":"J. Headache Pain."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107355_bib11","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1468-2982.1997.1704518.x","article-title":"Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat","volume":"17","author":"Williamson","year":"1997","journal-title":"Cephalalgia"},{"issue":"Pt 3","key":"10.1016\/j.clineuro.2022.107355_bib12","first-page":"427","article-title":"Human in vivo evidence for trigeminovascular activation in cluster headache","volume":"117","author":"Goadsby","year":"1994","journal-title":"Neuropept. Chang. Eff. Acute attacks Ther. Brain"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107355_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1468-2982.1994.1402088.x","article-title":"Demonstration of neuropeptide containing nerves and vasomotor responses to perivascular peptides in human cerebral arteries","volume":"14","author":"Edvinsson","year":"1994","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.clineuro.2022.107355_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0165-6147(00)01555-8","article-title":"The molecular pharmacology of CGRP and related peptide receptor subtypes","volume":"21","author":"Juaneda","year":"2000","journal-title":"Trends Pharm. Sci."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107355_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1468-2982.1996.1605310.x","article-title":"Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase","volume":"16","author":"Jansen-Olesen","year":"1996","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.clineuro.2022.107355_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.20619","article-title":"Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine","volume":"58","author":"Levy","year":"2005","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107355_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.clineuro.2022.107355_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107528","article-title":"Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans","volume":"211","author":"de Vries","year":"2020","journal-title":"Pharm. Ther."},{"issue":"Suppl 2","key":"10.1016\/j.clineuro.2022.107355_bib19","first-page":"3","article-title":"Targeting CGRP and 5-HT","volume":"59","author":"Moreno-Ajona","year":"2019","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.CIR.98.1.25","article-title":"Coronary side-effect potential of current and prospective antimigraine drugs","volume":"98","author":"MaassenVanDenBrink","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107355_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pharmthera.2009.09.003","article-title":"The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs","volume":"124","author":"Villal\u00f3n","year":"2009","journal-title":"Pharm. Ther."},{"issue":"23","key":"10.1016\/j.clineuro.2022.107355_bib22","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the treatment of migraine","volume":"381","author":"Dodick","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107355_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa2035908","article-title":"Atogepant for the preventive treatment of migraine","volume":"385","author":"Ailani","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10268","key":"10.1016\/j.clineuro.2022.107355_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(20)32544-7","article-title":"Oral rimegepant for preventive treatment of migraine: a phase 2\/3, randomised, double-blind, placebo-controlled trial","volume":"397","author":"Croop","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2022.107355_bib25","unstructured":"Moore E., Fraley M.E., Bell I.M., et al. Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin GeneRelated Peptide Receptor. J Pharmacol Exp Ther. Jan 28 2020."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107355_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/bcp.12618","article-title":"CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment","volume":"80","author":"Edvinsson","year":"2015","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.clineuro.2022.107355_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","article-title":"Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier","volume":"1600","author":"Eftekhari","year":"2015","journal-title":"Brain Res."},{"issue":"Suppl 2","key":"10.1016\/j.clineuro.2022.107355_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/head.13081","article-title":"The trigeminovascular pathway: role of CGRP and CGRP Receptors in Migraine","volume":"57","author":"Edvinsson","year":"2017","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s10194-020-01134-1","article-title":"The fifth cranial nerve in headaches","volume":"21","author":"Edvinsson","year":"2020","journal-title":"J. Headache Pain."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107355_bib30","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1177\/0333102419840780","article-title":"A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody","volume":"39","author":"Kielbasa","year":"2019","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.clineuro.2022.107355_bib31","first-page":"933","article-title":"A first-in-class monoclonal antibody for migraine prevention","volume":"53","author":"Garland","year":"2019","journal-title":"Ann. Pharm."},{"issue":"13","key":"10.1016\/j.clineuro.2022.107355_bib32","doi-asserted-by":"crossref","first-page":"e1365","DOI":"10.1212\/WNL.0000000000009169","article-title":"Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2","volume":"94","author":"Lipton","year":"2020","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.clineuro.2022.107355_bib33","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa1709038","article-title":"Fremanezumab for the preventive treatment of chronic migraine","volume":"377","author":"Silberstein","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2022.107355_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fimmu.2016.00021","article-title":"Immunogenicity to biotherapeutics - the role of anti-drug immune complexes","volume":"7","author":"Krishna","year":"2016","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10194-020-01211-5","article-title":"Immunogenicity of biologic therapies for migraine: a review of current evidence","volume":"22","author":"Cohen","year":"2021","journal-title":"J. Headache Pain."},{"issue":"30","key":"10.1016\/j.clineuro.2022.107355_bib36","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1523\/JNEUROSCI.0576-17.2017","article-title":"Selective inhibition of trigeminovascular neurons by fremanezumab: a humanized monoclonal anti-CGRP antibody","volume":"37","author":"Melo-Carrillo","year":"2017","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107355_bib37","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jpain.2013.03.010","article-title":"Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system","volume":"14","author":"Eftekhari","year":"2013","journal-title":"J. Pain."},{"issue":"44","key":"10.1016\/j.clineuro.2022.107355_bib38","doi-asserted-by":"crossref","first-page":"10587","DOI":"10.1523\/JNEUROSCI.2211-17.2017","article-title":"Fremanezumab-a humanized monoclonal anti-CGRP antibody-inhibits thinly myelinated (A\u03b4) but not unmyelinated (C) meningeal nociceptors","volume":"37","author":"Melo-Carrillo","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.clineuro.2022.107355_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420927119","article-title":"The role of erenumab in the treatment of migraine","volume":"13","author":"Andreou","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"11","key":"10.1016\/j.clineuro.2022.107355_bib40","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/0333102414527648","article-title":"Selective inhibition of meningeal nociceptors by botulinum neurotoxin type a: therapeutic implications for migraine and other pains","volume":"34","author":"Burstein","year":"2014","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.clineuro.2022.107355_bib41","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/head.13843","article-title":"Dual therapy with anti-CGRP monoclonal antibodies and botulinum toxin for migraine prevention: is there a rationale?","volume":"60","author":"Pellesi","year":"2020","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.clineuro.2022.107355_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3171\/2009.9.JNS09626","article-title":"Prevalence and impact of diffuse axonal injury in patients with moderate and severe head injury: a cohort study of early magnetic resonance imaging findings and 1-year outcome","volume":"113","author":"Skandsen","year":"2010","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2022.107355_bib43","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fncel.2019.00528","article-title":"Traumatic brain injuries: pathophysiology and potential therapeutic targets","volume":"13","author":"Ng","year":"2019","journal-title":"Front Cell Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1017\/cjn.2018.361","article-title":"Narrative review of the pathophysiology of headaches and photosensitivity in mild traumatic brain injury and concussion","volume":"46","author":"Mares","year":"2019","journal-title":"Can. J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.clineuro.2022.107355_bib45","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1007\/s11064-020-03141-9","article-title":"Exogenous CGRP regulates apoptosis and autophagy to alleviate traumatic brain injury through Akt\/mTOR signalling pathway","volume":"45","author":"Tian","year":"2020","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib46","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12031-017-1006-x","article-title":"Neuroprotective effect of curcumin against cerebral ischemia-reperfusion via mediating autophagy and inflammation","volume":"64","author":"Huang","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.clineuro.2022.107355_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuroscience.2011.03.021","article-title":"Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice","volume":"184","author":"Luo","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.clineuro.2022.107355_bib48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2017.08.042","article-title":"Suppression of FoxO3a attenuates neurobehavioral deficits after traumatic brain injury through inhibiting neuronal autophagy","volume":"337","author":"Sun","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.clineuro.2022.107355_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fnmol.2018.00190","article-title":"Autophagy in traumatic brain injury: a new target for therapeutic intervention","volume":"11","author":"Zhang","year":"2018","journal-title":"Front Mol. Neurosci."},{"issue":"13","key":"10.1016\/j.clineuro.2022.107355_bib50","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1089\/neu.2016.4764","article-title":"Extracellular signal-regulated kinase\/nuclear factor-erythroid2-like2\/heme oxygenase-1 pathway-mediated mitophagy alleviates traumatic brain injury-induced intestinal mucosa damage and epithelial barrier dysfunction","volume":"34","author":"Liu","year":"2017","journal-title":"J. Neurotrauma"},{"issue":"7","key":"10.1016\/j.clineuro.2022.107355_bib51","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/jnr.22314","article-title":"Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model","volume":"88","author":"Rosenbaum","year":"2010","journal-title":"J. Neurosci. Res"},{"issue":"4","key":"10.1016\/j.clineuro.2022.107355_bib52","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/HJH.0000000000001649","article-title":"Endogenous calcitonin gene-related peptide suppresses ischemic brain injuries and progression of cognitive decline","volume":"36","author":"Zhai","year":"2018","journal-title":"J. Hypertens."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107355_bib53","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.4103\/1673-5374.238619","article-title":"Relationship of calcitonin gene-related peptide with disease progression and prognosis of patients with severe traumatic brain injury","volume":"13","author":"Chen","year":"2018","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib54","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s13054-020-03342-2","article-title":"Rethinking brain injury after subarachnoid hemorrhage","volume":"24","author":"Amodio","year":"2020","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib55","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41467-022-28204-z","article-title":"Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice","volume":"13","author":"De Logu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clineuro.2022.107355_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejphar.2019.01.007","article-title":"Vascular pathology of large cerebral arteries in experimental subarachnoid hemorrhage: Vasoconstriction, functional CGRP depletion and maintained CGRP sensitivity","volume":"846","author":"Johansson","year":"2019","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107355_bib57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/02688699008992720","article-title":"Calcitonin gene-related peptide-LI in subarachnoid haemorrhage in man. Signs of activation of the trigemino-cerebrovascular system?","volume":"4","author":"Juul","year":"1990","journal-title":"Br. J. Neurosurg."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib58","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0304-3940(94)90240-2","article-title":"Calcitonin gene-related peptide (human alpha-CGRP) counteracts vasoconstriction in human subarachnoid haemorrhage","volume":"170","author":"Juul","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107355_bib59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3171\/jns.1989.71.4.0558","article-title":"Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs","volume":"71","author":"Nozaki","year":"1989","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107355_bib60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0090-3019(96)00048-1","article-title":"Effect of calcitonin gene-related peptide on delayed cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits","volume":"46","author":"Imaizumi","year":"1996","journal-title":"Surg. Neurol."},{"issue":"1\u20134","key":"10.1016\/j.clineuro.2022.107355_bib61","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF01541797","article-title":"Effect of intracisternal and intravenous calcitonin gene-related peptide on experimental cerebral vasospasm in rabbits","volume":"119","author":"Toshima","year":"1992","journal-title":"Acta Neurochir."},{"issue":"10","key":"10.1016\/j.clineuro.2022.107355_bib62","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1007\/BF01809753","article-title":"Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage","volume":"138","author":"Ahmad","year":"1996","journal-title":"Acta Neurochir."},{"issue":"5","key":"10.1016\/j.clineuro.2022.107355_bib63","first-page":"984","article-title":"Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys","volume":"39","author":"Inoue","year":"1996","journal-title":"Neurosurgery"},{"issue":"9","key":"10.1016\/j.clineuro.2022.107355_bib64","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.RES.87.9.818","article-title":"Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage","volume":"87","author":"Toyoda","year":"2000","journal-title":"Circ. Res"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107355_bib65","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3171\/jns.2002.97.1.0136","article-title":"Posttreatment with adenovirus-mediated gene transfer of calcitonin gene-related peptide to reverse cerebral vasospasm in dogs","volume":"97","author":"Satoh","year":"2002","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2022.107355_bib66","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2741\/e209","article-title":"Intranasal delivery of calcitonin gene-related peptide reduces cerebral vasospasm in rats","volume":"2","author":"Sun","year":"2010","journal-title":"Front Biosci."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722002360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722002360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:40:59Z","timestamp":1759588859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722002360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":66,"alternative-id":["S0303846722002360"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107355","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcitonin gene-related peptide and neurologic injury: An emerging target for headache management","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107355"}}